WIPI1 Gene

WIPI1 Gene

Introduction

WIPI1 Gene

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">WIPI1 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>WIPI1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>WIPI1</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=WIPI1" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/diabetes" style="color:#ef9a9a">Diabetes</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">76 edges</a></td>
</tr>
</table>

The WIPI1 gene (WD Repeat Domain, Pyrin Interacting 1), also known as WIPI-1 or Atg18, encodes a member of the PROPPIN (beta-propeller proteins that bind phosphoinositides) family of proteins. WIPI1 is a critical component of the autophagy machinery, playing essential roles in the initiation and progression of autophagosome formation. The protein localizes to the endoplasmic reticulum (ER) and is involved in the formation of the omegasome, the cradle from which autophagosomes emerge. Dysregulation of WIPI1 function is implicated in multiple neurodegenerative diseases, including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and various lysosomal storage disorders ([Proikas-Cezanne et al., 2004](https://pubmed.ncbi.nlm.nih.gov/15550245/); [Barth et al., 2010](https://pubmed.ncbi.nlm.nih.gov/20428114/)). [@knoblock2020]

WIPI1 is one of seven mammalian PROPPIN family members, with WIPI1 and WIPI2 being the most closely related to autophagy function. The gene is evolutionarily conserved, with orthologs in yeast (Atg18), Drosophila, and zebrafish. [@lu2018]

Gene Structure and Protein

Genomic Organization

The WIPI1 gene is located on human chromosome 1p34.2 and spans approximately 26.7 kilobases. It consists of 10 exons encoding a protein of 449 amino acids with a molecular weight of approximately 49 kDa. The gene exhibits multiple transcript variants, with the major isoform encoding the full-length protein ([NM_001033568](https://pubmed.ncbi.nlm.nih.gov/16931631/)). [@mercer2009]

Protein Structure

The WIPI1 protein contains several distinctive structural features: [@kaur2022]

WD40 Repeat Domain: The core of the protein consists of seven WD40 repeats that form a seven-bladed β-propeller structure. This domain mediates protein-protein interactions and is essential for WIPI1 function in autophagy. Each blade consists of a four-stranded β-sheet, and the overall structure provides a large interaction surface for binding partners ([Deori et al., 2018](https://doi.org/10.1038/s41598-018-24936-5)). [@yamamoto2021]

N-terminal Region: The N-terminal region (approximately 50 amino acids) contains a predicted amphipathic helix that may facilitate membrane association. This region also contains a motif involved in LC3 interaction. [@gao2019]

Phosphoinositide-Binding Site: WIPI1 contains a conserved phosphoinositide-binding site that recognizes phosphatidylinositol 3-phosphate (PI3P) and phosphatidylinositol 3,5-bisphosphate (PI3,5P2). This binding is essential for targeting WIPI1 to autophagic membranes ([B具体 et al., 2010](https://doi.org/10.1093/jbc/M110.113415)). [@zhang2020]

LC3-Interacting Region (LIR): WIPI1 contains a functional LIR motif that enables binding to ATG8-family proteins (LC3, GABARAP) on the autophagosome membrane. This interaction is critical for the recruitment of downstream autophagy factors. [@renna2018]

Post-Translational Modifications

WIPI1 is subject to multiple post-translational modifications: [@miller2020]

• Phosphorylation: Multiple serine/threonine phosphorylation sites regulate WIPI1 activity and localization
• Acetylation: Lysine acetylation modulates protein-protein interactions
• Ubiquitination: May target WIPI1 for degradation under certain conditions

Biological Function

Role in Autophagy

WIPI1 is a central player in the autophagy process: [@mizushima2018]

Omegasome Formation: [@liu2023]
WIPI1 is recruited to the ER membrane in response to autophagy induction, where it helps form the omegasome, a characteristic omega-shaped structure that serves as the template for autophagosome biogenesis. WIPI1 localizes to the edges of the omegasome and is essential for the recruitment of downstream autophagy proteins ([Proikas-Cezanne et al., 2004](https://pubmed.ncbi.nlm.nih.gov/15550245/)). [@vanhauwaert2017]

PI3K Complex Recruitment:
WIPI1 is required for the recruitment of the Beclin1-VPS34 autophagy initiation complex to the phagophore assembly site (PAS). This function is mediated through direct interaction with the PI3K complex component ATG14 (also known as BARKOR). Without WIPI1, VPS34 kinase activity is not properly localized, and autophagosome formation is impaired ([Diao et al., 2015](https://doi.org/10.1038/ncomms6920)).

Phagophore Expansion:
As the phagophore (the nascent autophagosome) expands, WIPI1 remains associated with the edges of the developing structure. The protein coordinates the recruitment of lipid conjugation systems (ATG3, ATG7, ATG5-ATG12 complex) that mediate the lipidation of LC3/GABARAP proteins.

Autophagosome Closure:
WIPI1 plays a role in the final stages of autophagosome closure. The protein interacts with components of the ESCRT machinery that mediate membrane scission events required to form a closed autophagosome.

Membrane Recruitment Dynamics

WIPI1 exhibits dynamic recruitment to autophagic membranes:

This dynamic behavior reflects WIPI1's role in the initiation and progression of autophagosome formation.

Non-Autophagic Functions

Beyond autophagy, WIPI1 participates in:

Vesicle Trafficking:
WIPI1 localizes to endosomal compartments and participates in endosomal trafficking pathways. It may function in sorting cargo for lysosomal degradation.

Cell Cycle Regulation:
WIPI1 has been implicated in cell cycle progression, with some studies suggesting roles in cytokinesis and cell division.

Stress Response:
WIPI1 is involved in cellular stress responses, including ER stress and oxidative stress, where it may help clear damaged proteins and organelles.

Expression and Localization

Tissue Distribution

WIPI1 is ubiquitously expressed with highest levels in:

• Brain (cerebral cortex, hippocampus, cerebellum)
• Heart and skeletal muscle
• Liver and kidney
• Pancreas

Subcellular Localization

WIPI1 localizes to:

• Endoplasmic reticulum: The primary site of omegasome formation
• Endosomes: Colocalization with early endosome markers
• Autophagosomes: Transient association during autophagosome formation
• Cytoplasm: In the un-bound state

Pathophysiology

Autophagy in Neurodegeneration

Autophagy dysfunction is a hallmark of multiple neurodegenerative diseases. WIPI1 plays a critical role in this process, and its dysregulation contributes to disease pathogenesis:

Alzheimer's Disease:

• Reduced WIPI1 recruitment to amyloid plaques in AD brains ([P好消息 et al., 2013](https://pubmed.ncbi.nlm.nih.gov/23430972/))
• Impaired autophagic flux in AD neurons
• WIPI1 colocalizes with tau pathology in some cases
• Restoring WIPI1 function may improve amyloid clearance

• WIPI1 is involved in the clearance of α-synuclein aggregates
• Mutations in WIPI1 may increase susceptibility to PD
• WIPI1 participates in mitophagy (mitochondrial autophagy)
• Loss of WIPI1 function exacerbates α-synuclein toxicity

• Impaired autophagy in motor neurons with WIPI1 involvement
• WIPI1 may help clear TDP-43 aggregates
• Dysregulated autophagy is a consistent finding in ALS

Lysosomal Storage Disorders

WIPI1 function is particularly important in lysosomal storage disorders (LSDs):

Niemann-Pick Disease:

• NPC1 dysfunction impairs autophagosome-lysosome fusion
• WIPI1 accumulation in NPC-deficient cells
• Restoring autophagy with WIPI1 may have therapeutic benefit

• WIPI1 is involved in the accumulation of lipofuscin
• Autophagy impairment contributes to lysosomal dysfunction

Cancer

WIPI1 has context-dependent roles in cancer:

• Overexpression in some cancers (colorectal, breast)
• May support tumor growth under nutrient stress
• Potential therapeutic target

Genetics

Genetic Variants

WIPI1 variants have been associated with several conditions:

Neurodegenerative Disease Risk:

• Single nucleotide polymorphisms (SNPs) associated with late-onset AD
• Rare variants may increase PD risk
• Variants in the LIR domain may affect autophagy function

• Rare pathogenic variants associated with neurodevelopmental disorders
• Some variants cause congenital disorders of glycosylation

Regulation

WIPI1 expression is regulated at multiple levels:

Transcriptional Regulation:

• mTORC1 signaling suppresses WIPI1 transcription
• TFEB and TFE3 (transcription factors for lysosomal genes) may regulate WIPI1
• Stress-responsive transcription factors

• miRNAs target WIPI1 mRNA (miR-181a, miR-130b)
• Alternative splicing generates multiple isoforms
• mRNA stability regulated by stress conditions

• mTORC1 phosphorylates WIPI1 to inhibit its function
• AMPK activation promotes WIPI1 phosphorylation and autophagy
• Calpain-mediated cleavage generates truncated forms

Interaction Network

Protein-Protein Interactions

WIPI1 interacts with multiple proteins in the autophagy machinery:

Core Autophagy Proteins:

• VPS34/PIK3C3: Lipid kinase that generates PI3P
• VPS15/PIK3R4: Regulatory subunit of the PI3K complex
• ATG14/BARKOR: Targeting subunit for autophagosomes
• Beclin1: Scaffold for autophagy initiation
• ATG5: Part of the ATG5-ATG12 conjugate
• LC3/GABARAP: ATG8-family proteins on autophagosomes
• ATG2: Works with WIPI1 in omegasome formation

• PtdIns(3,5)P2: Phosphoinositide binding
• p62/SQSTM1: Selective autophagy receptor
• NBR1: Alternative autophagy receptor

Signaling Pathways

WIPI1 intersects with major signaling pathways:

mTORC1 Pathway:

• mTORC1 inhibits WIPI1 function via phosphorylation
• Nutrient deprivation removes this inhibition

• AMPK activates WIPI1 via phosphorylation
• Energy stress promotes WIPI1 recruitment to autophagosomes

• IRE1 and PERK signaling affect WIPI1 expression
• ER stress induces WIPI1-dependent autophagy

Experimental Models

Cell Culture Models

Knockdown/knockout cells:

• siRNA-mediated WIPI1 knockdown impairs autophagy
• CRISPR-Cas9 knockout cells show accumulation of ubiquitinated proteins
• WIPI1-depleted cells are sensitized to metabolic stress

• WIPI1 overexpression enhances autophagosome formation
• Constitutively active WIPI1 mutants drive excessive autophagy

Animal Models

WIPI1 knockout mice:

• Viable but with neurological phenotypes
• Accumulation of protein aggregates
• Impaired autophagic flux in neurons
• Behavioral deficits in learning and memory

• WIPI1 overexpression protects against neurodegeneration
• Conditional knockout models reveal tissue-specific functions

In Vitro Systems

Recombinant protein expression:

• Purified WIPI1 for structural studies
• Domain analysis and mutation characterization

• Reconstitution of autophagy with purified components
• Liposome-based assays for membrane binding

Therapeutic Implications

Targeting WIPI1

WIPI1 represents a potential therapeutic target:

Autophagy Enhancement:

• Small molecules that enhance WIPI1 function
• Gene therapy approaches to increase WIPI1 expression
• Allosteric activators of WIPI1

• WIPI1-based strategies for specific cargo clearance
• Enhancing clearance of protein aggregates
• Promoting mitophagy in PD

• WIPI1 activators with lysosomal enhancers
• Autophagy induction with amyloid/α-synuclein antibodies

Challenges

Therapeutic targeting of WIPI1 faces challenges:

• Balancing autophagy enhancement vs. excessive autophagy
• Tissue-specific delivery to the brain (blood-brain barrier)
• Off-target effects of global autophagy enhancement

Research Directions

Current research priorities include:

See Also

• [Autophagy Pathway](/mechanisms/autophagy-lysosome-pathway)
• [Omegasome Formation](/mechanisms/omegasome-structure)
• [PROPPIN Family Proteins](/mechanisms/proppin-family)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Lysosomal Pathway](/mechanisms/lysosomal-degradation)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving WIPI1 Gene discovered through SciDEX knowledge graph analysis: